Recent Searches
Trending
M&A outlook: stronger US deal market in 2026 despite mixed economic signals
28 Oct 2025 GrowthUS Healthcare Cyber Resilience Survey: Why elevating cybersecurity to a strategic priority can drive transformation
03 Nov 2025Beyond cost cutting: AI as the ultimate growth engine
03 Nov 2025 ConsultingEY-Parthenon Life Sciences Strategy Consulting teams can advise clients on developing transformative growth strategies by providing broad market, competitor and customer insights. But a strategy alone is not enough: we also help organizations execute strategy through real operational change. We help them transform the vision into reality by leveraging strategic, financial and operational perspectives based on deep sector experience and firmwide knowledge to help enable end-to-end execution to address society’s most pressing health problems.
What the EY-Parthenon Life Sciences Strategy Consulting team can do for you
As the life sciences industry transforms in the face of regulatory and geopolitical uncertainty and new ways of developing treatments, EY-Parthenon teams can help you answer some of your most critical questions:
Transformative strategy
Transformative transactions
The EY-Parthenon Life Sciences team helps Biopharma, Medtech, Biotech and Tools and Services companies develop and deliver growth through enterprise, digital and value creation strategies and transformative transactions. Our advice is grounded in financial and operational rigor, helping companies remain resilient in a fast-changing geopolitical landscape.
Our focus includes:
Our latest thinking
Pulse of the MedTech Industry Report
EY MedTech report on dealmaking, financing and state of the industry, with insights on growth and commercial strategies, AI, consumer and more.
How Bristol Myers Squibb overhauled working capital to fund its future
EY-Parthenon team helped BMS establish a cash leadership office as part of an award-winning Treasury transformation. Learn more in this case study.
Investing in innovation: unlocking value in MedTech
An analysis of value creation among MedTech sector companies underscores the pivotal role of investment in R&D as a driver of long-term value creation.
When and how to use GenAI in late-stage clinical development
Discover the impact of GenAI in clinical trials, including potentially improved trial design and streamlined regulatory processes for drug development.
Beyond integration: Value creation from bolt-on life sciences deals
Discover strategies for successful bolt-on acquisitions in life sciences for 2025. Read the full article for essential insights.
How life sciences CIOs can make the most of GenAI investments
Optimism about GenAI is spreading among CIOs of life sciences organizations, which must focus on key priorities to benefit from the technology. Read more.
Key steps for improving biopharma expansion into new markets
As biopharma companies look to new markets for needed growth, leaders need to tailor the expansion approach to the nuances of each market. Learn more.
How pharma can benefit from using GenAI in drug discovery
Using GenAI in drug discovery is a hot topic in the pharmaceutical industry, with speed and cost savings seen as potential benefits. Learn more.
5 steps life sciences companies can take now to build resiliency
Life sciences executives focus on cost containment and agility in the face of economic and legislative challenges. Learn more.
How retail pharmacies can transform clinical trials
Retail pharmacies have a strong opportunity to increase their presence in clinical drug trials, expanding the pool of trial participants.
How an acquisition helped Orifarm prepare a prescription for growth
EY teams help founder-run Orifarm, a Danish pharmaceuticals company, embark on the path to transformation.
How EY-Parthenon can help
EY-Parthenon professionals can help your business design and provide transformative strategies for sustainable growth. Learn more.
Read moreLearn how EY-Parthenon M&A Advisory Services teams can help enable strategic growth through integrated M&As, joint ventures and alliances.
Read moreDiscover how EY enables enterprise transformation that helps companies drive growth and unlock value.
Read more
